Clinical Research

Canadian Phase Onward Inc. (CPO) was opened in 2004 due to the growing interest from pharmaceutical companies in more non-hospital based Canadian sites to participate in their diverse clinical trials. CPO is located at the same site, and operates in tandem with, the Polyclinic Family and Specialty Medicine Facility, resulting in a referral network of more than 30 specialists and 15 family physicians.

CPO boasts principal investigator(s) with extensive experience in Phase 2, 3 and 4 clinical research trials in a wide range of all diagnostic areas including but not limited to smoking cessation, diabetes, erectile dysfunction, hypertension, cardiovascular (general), migraine, obesity, GERD, irritable bowel syndrome, constipation, diabetic peripheral neuropathy, metabolic syndrome, insomnia, pain relief, fibromyalgia, COPD, asthma, schizophrenia, and depression. CPO also has experience in vaccine studies.

CPO has been one of the sites of choice by some of the largest pharmaceutical companies including Janssen, Merck, Eli Lilly, Boehringer Ingelheim, GSK, Pfizer, Novartis, Sanofi-Aventis and AstraZeneca.

CPO also focuses on the benefits that participating in these clinical trials may offer to our patients, including more intensive physician care, potential access to treatment options that may not otherwise be available, and free medications and testing. This is a great complement to the Polyclinic Family and Specialty Medicine Facility.

Collaboration with the Polyclinic Family and Specialty Medicine Facility, also enables CPO to provide a continuity of care to its study patients through regular correspondence with each patient’s physician. This makes for good clinical practice and provides a level of care that is not otherwise available at sites that operate simply as independent research facilities.